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Thymic stromal lymphopoietin (TSLP) is an epithelial cell-de-
rived cytokine expressed in skin, gut, lungs, and thymus. TSLP 
signals via the TSLP receptor (TSLPR), a heterodimer of the IL-7 
receptor α chain and TSLPR chain. The TSLPR chain is closely 
related to the common receptor γ chain, which is expressed on 
a wide range of cell types in allergic inflammation. TSLP exerts 
a profound influence on the polarization of dendritic cells to 
drive T helper (Th) 2 cytokine production.
1 TSLP also promotes 
T-cell proliferation directly in response to T-cell receptor activa-
tion and Th2 cytokine production, and supports B-cell expan-
sion and differentiation. TSLP further amplifies Th2 cytokine 
production by mast cells and natural killer T cells.
2 These prop-
erties confer a critical role on TSLP in driving Th2-mediated in-
flammation. Several studies have suggested an active role of 
TSLP in allergic diseases, including atopic dermatitis, asthma, 
and allergic rhinitis, because increased TSLP expression was 
noted in target tissues.
3,4 Additionally, increased TSLP expres-
sion is seen in inflammatory conditions in response to a wide 
variety of allergens and viral infections
5-7 and in eosinophilic 
esophagitis.
8,9 Regarding the role of TSLP in nasal polyps, one 
study suggested increased TSLP expression in nasal polyp tis-
sue, but it did not demonstrate any relationship between TSLP 
and any major inflammatory parameter, such as eosinophilic 
infiltration.
4
The study by Kimura et al.
10 in this issue of the AAIR clearly 
demonstrated increased in vivo expression of TSLP mRNA and 
protein in the epithelial and infiltrating cells of patients with na-
sal polyps regardless of their atopic status. Furthermore, they 
showed that the TSLP expression correlated closely with the 
degree of eosinophilic inflammation and local IgE level in nasal 
polyp tissue. These findings suggest a potential role of TSLP in 
the pathogenesis of chronic inflammation found in nasal pol-
yps via regulating Th2 and eosinophilic inflammation. More-
over, the authors localized the source of TSLP within the nasal 
polyp tissue, and noted TSLP expression in inflammatory cells, 
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various structural cells, and epithelial cells. These levels corre-
lated significantly with the number of eosinophils in nasal pol-
yp tissue, indicating that TSLP derived primarily from epithelial 
cells has a role in regulating eosinophilic inflammation in nasal 
polyps, possibly by driving Th2 type inflammation, which up-
regulates eosinophilic chemoattractants.
Several points should be clarified in future studies. First, in-
creased TSLP expression was noted in both atopic and non-
atopic groups. In the atopic group, allergen exposure could in-
crease TSLP expression, as described in previous studies, be-
cause it was demonstrated that allergen exposure increased 
TSLP production from bronchial epithelial cells, which would 
enhance Th2-derived inflammation in asthmatic airways.
11,12 
However, the mechanism of elevated TSLP expression in the 
nasal polyp tissue of the non-atopic group is not understood. 
Second, because the mast cell is a major inflammatory cell in 
nasal polyp tissue and TSLP can active mast cells as well as eo-
sinophils, further studies should investigate the roles of TSLP in 
the survival and recruitment of mast cells in nasal polyps.
Recent interesting findings suggest that respiratory viral infec-
tions and the recruitment of Th2 cytokine-producing cells am-
plify Th2 inflammation via the induction of TSLP.
5 The clinical 
features of aspirin-exacerbated respiratory disease (AERD) in-
clude a very high prevalence of chronic rhinosinusitis and na-
sal polyposis in which Th2 and eosinophilic inflammations are 
the major findings.
13 Compared with other types of nasal polyp, 
the increased activated status of eosinophils is a characteristic 
finding of chronic nasal polyp tissue in AERD patients.
14 In this 
Editorial
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study, the subjects were classified into two groups according to 
their atopic status. They did not enroll nasal polyps from AERD 
patients. Thus, the next strategy is to evaluate the role of TSLP in 
chronic eosinophilic inflammation of nasal polyp tissue in AERD 
patients compared with non-AERD patients.
Several studies suggest that AERD develops as a result of chron-
ic viral infection,
15-17 and respiratory viral infections are the most 
frequent exacerbating factors in AERD patients.
18 Moreover, a 
recent study showed that two genetic polymorphisms of the 
Toll-like receptor, TLR3, at -299698G>T and 293391G>A, were 
associated with the AERD phenotype.
19 Further studies are 
needed to investigate the role of TSLP in the development and 
exacerbation of symptoms in AERD patients.
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